← Back to All US Stocks

CGC Stock Analysis - Canopy Growth Corp AI Rating

CGC Nasdaq Medicinal Chemicals & Botanical Products Z4 CIK: 0001737927
Recently Updated • Analysis: Mar 22, 2026 • SEC Data: 2025-12-31
AI Rating
HOLD
15% Confidence

📊 CGC Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: HOLD with 15% confidence

Investment Thesis

Insufficient financial data available for fundamental analysis. With only 2 metrics available and most key financial indicators marked as N/A, a meaningful assessment of profitability trends, financial health, and growth quality cannot be performed. Data quality and availability severely limit analytical capability.

CGC Strengths

  • + Recent insider activity with 3 Form 4 filings in last 90 days suggests management engagement
  • + Listed on Nasdaq indicating established public company status
  • + Operates in medicinal chemicals sector with potential long-term market demand

CGC Risks

  • ! Critical data unavailability - revenue, net income, and profitability metrics are all N/A
  • ! Complete absence of balance sheet detail prevents assessment of financial stability and leverage
  • ! No cash flow data available to evaluate operational efficiency or capital allocation
  • ! Extremely limited metrics (only 2 of numerous standard metrics) prevents fundamental analysis
  • ! Data freshness date of 2025-12-31 is future-dated, indicating potential data integrity issues

Key Metrics to Watch

CGC Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

CGC Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

CGC vs Default Sector

How Canopy Growth Corp compares to Default sector averages

Net Margin
CGC 0.0%
vs
Sector Avg 12.0%
CGC Sector
ROE
CGC 0.0%
vs
Sector Avg 15.0%
CGC Sector
Current Ratio
CGC 0.0x
vs
Sector Avg 1.8x
CGC Sector
Debt/Equity
CGC 0.0x
vs
Sector Avg 0.7x
CGC Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CGC Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

CGC Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

CGC SEC Filings

Access official SEC EDGAR filings for Canopy Growth Corp (CIK: 0001737927)

📋 Recent SEC Filings

Date Form Document Action
Mar 16, 2026 8-K tm268860d1_8k.htm View →
Feb 12, 2026 4 xslF345X05/tm266247-1_4seq1.xml View →
Feb 6, 2026 8-K cgc-20260206.htm View →
Feb 6, 2026 10-Q cgc-20251231.htm View →
Jan 8, 2026 8-K tm262514d3_8k.htm View →

Frequently Asked Questions about CGC

What is the AI rating for CGC?

Canopy Growth Corp (CGC) has an AI rating of HOLD with 15% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CGC's key strengths?

Recent insider activity with 3 Form 4 filings in last 90 days suggests management engagement. Listed on Nasdaq indicating established public company status.

What are the risks of investing in CGC?

Critical data unavailability - revenue, net income, and profitability metrics are all N/A. Complete absence of balance sheet detail prevents assessment of financial stability and leverage.

What is CGC's revenue and growth?

Canopy Growth Corp reported revenue of N/A.

Does CGC pay dividends?

Canopy Growth Corp does not currently pay dividends.

Where can I find CGC SEC filings?

Official SEC filings for Canopy Growth Corp (CIK: 0001737927) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CGC's EPS?

Canopy Growth Corp has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 22, 2026 | Data as of: 2025-12-31 | Powered by Claude AI